ARTICLE | Company News
DiaKine, Kinexum Metabolics Inc. deal
May 12, 2008 7:00 AM UTC
The companies partnered to develop a combination of DiaKine’s lisofylline and Kinexum’s islet neogenesis associated protein (INGAP) peptide to treat Type I diabetes. The companies will co-own the resu...